Industry Research Reports

Home > Reports > Medical Care > Contract Research Organization (CRO) and CDMO for Pharmaceutical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Contract Research Organization (CRO) and CDMO for Pharmaceutical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published: 2024-01-12

Pages: 129 Pages

Report ld: 2627539

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Contract Research Organization (CRO) and CDMO for Pharmaceutical was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Contract Research Organization (CRO) and CDMO for Pharmaceutical, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Contract Research Organization (CRO) and CDMO for Pharmaceutical by region & country, by Type, and by Application.

The Contract Research Organization (CRO) and CDMO for Pharmaceutical market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contract Research Organization (CRO) and CDMO for Pharmaceutical.

Market Segmentation

Report Metric
Details
Report Title
Contract Research Organization (CRO) and CDMO for Pharmaceutical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Companies Covered
IQVIA, ICON (Incl. PRA), Labcorp, Syneos Health, PPD (Thermo Fisher), Medpace, Parexel, Wuxi Apptec, Charles River, Pharmaron, EPS International, Worldwide Clinical Trials, CMIC, Inotiv, JOINN Lab, ChemPartner, Medicilon, EVOTEC
Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market, Segment by Type
Preclinical CROs

Clinical CROs
Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market, Segment by Application
Pharmaceutical & Biotechnological Companies

Medical Device Companies

Academic & Research Institutes

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Contract Research Organization (CRO) and CDMO for Pharmaceutical manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Contract Research Organization (CRO) and CDMO for Pharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Contract Research Organization (CRO) and CDMO for Pharmaceutical in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Contract Research Organization (CRO) and CDMO for Pharmaceutical Product Introduction
    1.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size Forecast
    1.3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Trends & Drivers
        1.3.1 Contract Research Organization (CRO) and CDMO for Pharmaceutical Industry Trends
        1.3.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Drivers & Opportunity
        1.3.3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Challenges
        1.3.4 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Players Revenue Ranking (2023)
    2.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Company (2019-2024)
    2.3 Key Companies Contract Research Organization (CRO) and CDMO for Pharmaceutical Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Contract Research Organization (CRO) and CDMO for Pharmaceutical Product Offered
    2.5 Key Companies Time to Begin Mass Production of Contract Research Organization (CRO) and CDMO for Pharmaceutical
    2.6 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Competitive Analysis
        2.6.1 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contract Research Organization (CRO) and CDMO for Pharmaceutical as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Preclinical CROs
        3.1.2 Clinical CROs
    3.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Type
        3.2.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value, by Type (2019-2030)
        3.2.3 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Pharmaceutical & Biotechnological Companies
        4.1.2 Medical Device Companies
        4.1.3 Academic & Research Institutes
        4.1.4 Others
    4.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Application
        4.2.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value, by Application (2019-2030)
        4.2.3 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Region
        5.1.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Region (2019-2024)
        5.1.3 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Region (2025-2030)
        5.1.4 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value, 2019-2030
        5.2.2 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value, 2019-2030
        5.3.2 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value, 2019-2030
        5.4.2 Asia Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value, 2019-2030
        5.5.2 South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value, 2019-2030
        5.6.2 Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value
    6.3 United States
        6.3.1 United States Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value, 2019-2030
        6.3.2 United States Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value, 2019-2030
        6.4.2 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value, 2019-2030
        6.5.2 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value, 2019-2030
        6.6.2 Japan Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value, 2019-2030
        6.7.2 South Korea Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value, 2019-2030
        6.8.2 Southeast Asia Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value, 2019-2030
        6.9.2 India Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 IQVIA
        7.1.1 IQVIA Profile
        7.1.2 IQVIA Main Business
        7.1.3 IQVIA Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
        7.1.4 IQVIA Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (US$ Million) & (2019-2024)
        7.1.5 IQVIA Recent Developments
    7.2 ICON (Incl. PRA)
        7.2.1 ICON (Incl. PRA) Profile
        7.2.2 ICON (Incl. PRA) Main Business
        7.2.3 ICON (Incl. PRA) Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
        7.2.4 ICON (Incl. PRA) Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (US$ Million) & (2019-2024)
        7.2.5 ICON (Incl. PRA) Recent Developments
    7.3 Labcorp
        7.3.1 Labcorp Profile
        7.3.2 Labcorp Main Business
        7.3.3 Labcorp Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
        7.3.4 Labcorp Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (US$ Million) & (2019-2024)
        7.3.5 Syneos Health Recent Developments
    7.4 Syneos Health
        7.4.1 Syneos Health Profile
        7.4.2 Syneos Health Main Business
        7.4.3 Syneos Health Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
        7.4.4 Syneos Health Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (US$ Million) & (2019-2024)
        7.4.5 Syneos Health Recent Developments
    7.5 PPD (Thermo Fisher)
        7.5.1 PPD (Thermo Fisher) Profile
        7.5.2 PPD (Thermo Fisher) Main Business
        7.5.3 PPD (Thermo Fisher) Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
        7.5.4 PPD (Thermo Fisher) Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (US$ Million) & (2019-2024)
        7.5.5 PPD (Thermo Fisher) Recent Developments
    7.6 Medpace
        7.6.1 Medpace Profile
        7.6.2 Medpace Main Business
        7.6.3 Medpace Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
        7.6.4 Medpace Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (US$ Million) & (2019-2024)
        7.6.5 Medpace Recent Developments
    7.7 Parexel
        7.7.1 Parexel Profile
        7.7.2 Parexel Main Business
        7.7.3 Parexel Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
        7.7.4 Parexel Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (US$ Million) & (2019-2024)
        7.7.5 Parexel Recent Developments
    7.8 Wuxi Apptec
        7.8.1 Wuxi Apptec Profile
        7.8.2 Wuxi Apptec Main Business
        7.8.3 Wuxi Apptec Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
        7.8.4 Wuxi Apptec Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (US$ Million) & (2019-2024)
        7.8.5 Wuxi Apptec Recent Developments
    7.9 Charles River
        7.9.1 Charles River Profile
        7.9.2 Charles River Main Business
        7.9.3 Charles River Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
        7.9.4 Charles River Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (US$ Million) & (2019-2024)
        7.9.5 Charles River Recent Developments
    7.10 Pharmaron
        7.10.1 Pharmaron Profile
        7.10.2 Pharmaron Main Business
        7.10.3 Pharmaron Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
        7.10.4 Pharmaron Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (US$ Million) & (2019-2024)
        7.10.5 Pharmaron Recent Developments
    7.11 EPS International
        7.11.1 EPS International Profile
        7.11.2 EPS International Main Business
        7.11.3 EPS International Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
        7.11.4 EPS International Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (US$ Million) & (2019-2024)
        7.11.5 EPS International Recent Developments
    7.12 Worldwide Clinical Trials
        7.12.1 Worldwide Clinical Trials Profile
        7.12.2 Worldwide Clinical Trials Main Business
        7.12.3 Worldwide Clinical Trials Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
        7.12.4 Worldwide Clinical Trials Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (US$ Million) & (2019-2024)
        7.12.5 Worldwide Clinical Trials Recent Developments
    7.13 CMIC
        7.13.1 CMIC Profile
        7.13.2 CMIC Main Business
        7.13.3 CMIC Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
        7.13.4 CMIC Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (US$ Million) & (2019-2024)
        7.13.5 CMIC Recent Developments
    7.14 Inotiv
        7.14.1 Inotiv Profile
        7.14.2 Inotiv Main Business
        7.14.3 Inotiv Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
        7.14.4 Inotiv Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (US$ Million) & (2019-2024)
        7.14.5 Inotiv Recent Developments
    7.15 JOINN Lab
        7.15.1 JOINN Lab Profile
        7.15.2 JOINN Lab Main Business
        7.15.3 JOINN Lab Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
        7.15.4 JOINN Lab Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (US$ Million) & (2019-2024)
        7.15.5 JOINN Lab Recent Developments
    7.16 ChemPartner
        7.16.1 ChemPartner Profile
        7.16.2 ChemPartner Main Business
        7.16.3 ChemPartner Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
        7.16.4 ChemPartner Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (US$ Million) & (2019-2024)
        7.16.5 ChemPartner Recent Developments
    7.17 Medicilon
        7.17.1 Medicilon Profile
        7.17.2 Medicilon Main Business
        7.17.3 Medicilon Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
        7.17.4 Medicilon Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (US$ Million) & (2019-2024)
        7.17.5 Medicilon Recent Developments
    7.18 EVOTEC
        7.18.1 EVOTEC Profile
        7.18.2 EVOTEC Main Business
        7.18.3 EVOTEC Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
        7.18.4 EVOTEC Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (US$ Million) & (2019-2024)
        7.18.5 EVOTEC Recent Developments

 8 Industry Chain Analysis
    8.1 Contract Research Organization (CRO) and CDMO for Pharmaceutical Industrial Chain
    8.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Model
        8.5.2 Sales Channel
        8.5.3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Trends
    Table 2. Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Drivers & Opportunity
    Table 3. Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Challenges
    Table 4. Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Restraints
    Table 5. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Contract Research Organization (CRO) and CDMO for Pharmaceutical Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Contract Research Organization (CRO) and CDMO for Pharmaceutical Product Type
    Table 9. Key Companies Time to Begin Mass Production of Contract Research Organization (CRO) and CDMO for Pharmaceutical
    Table 10. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contract Research Organization (CRO) and CDMO for Pharmaceutical as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Region (2019-2024) & (%)
    Table 27. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value, (2025-2030) & (US$ Million)
    Table 31. IQVIA Basic Information List
    Table 32. IQVIA Description and Business Overview
    Table 33. IQVIA Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business of IQVIA (2019-2024)
    Table 35. IQVIA Recent Developments
    Table 36. ICON (Incl. PRA) Basic Information List
    Table 37. ICON (Incl. PRA) Description and Business Overview
    Table 38. ICON (Incl. PRA) Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business of ICON (Incl. PRA) (2019-2024)
    Table 40. ICON (Incl. PRA) Recent Developments
    Table 41. Labcorp Basic Information List
    Table 42. Labcorp Description and Business Overview
    Table 43. Labcorp Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business of Labcorp (2019-2024)
    Table 45. Labcorp Recent Developments
    Table 46. Syneos Health Basic Information List
    Table 47. Syneos Health Description and Business Overview
    Table 48. Syneos Health Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business of Syneos Health (2019-2024)
    Table 50. Syneos Health Recent Developments
    Table 51. PPD (Thermo Fisher) Basic Information List
    Table 52. PPD (Thermo Fisher) Description and Business Overview
    Table 53. PPD (Thermo Fisher) Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business of PPD (Thermo Fisher) (2019-2024)
    Table 55. PPD (Thermo Fisher) Recent Developments
    Table 56. Medpace Basic Information List
    Table 57. Medpace Description and Business Overview
    Table 58. Medpace Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business of Medpace (2019-2024)
    Table 60. Medpace Recent Developments
    Table 61. Parexel Basic Information List
    Table 62. Parexel Description and Business Overview
    Table 63. Parexel Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business of Parexel (2019-2024)
    Table 65. Parexel Recent Developments
    Table 66. Wuxi Apptec Basic Information List
    Table 67. Wuxi Apptec Description and Business Overview
    Table 68. Wuxi Apptec Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business of Wuxi Apptec (2019-2024)
    Table 70. Wuxi Apptec Recent Developments
    Table 71. Charles River Basic Information List
    Table 72. Charles River Description and Business Overview
    Table 73. Charles River Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business of Charles River (2019-2024)
    Table 75. Charles River Recent Developments
    Table 76. Pharmaron Basic Information List
    Table 77. Pharmaron Description and Business Overview
    Table 78. Pharmaron Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business of Pharmaron (2019-2024)
    Table 80. Pharmaron Recent Developments
    Table 81. EPS International Basic Information List
    Table 82. EPS International Description and Business Overview
    Table 83. EPS International Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business of EPS International (2019-2024)
    Table 85. EPS International Recent Developments
    Table 86. Worldwide Clinical Trials Basic Information List
    Table 87. Worldwide Clinical Trials Description and Business Overview
    Table 88. Worldwide Clinical Trials Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business of Worldwide Clinical Trials (2019-2024)
    Table 90. Worldwide Clinical Trials Recent Developments
    Table 91. CMIC Basic Information List
    Table 92. CMIC Description and Business Overview
    Table 93. CMIC Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business of CMIC (2019-2024)
    Table 95. CMIC Recent Developments
    Table 96. Inotiv Basic Information List
    Table 97. Inotiv Description and Business Overview
    Table 98. Inotiv Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business of Inotiv (2019-2024)
    Table 100. Inotiv Recent Developments
    Table 101. JOINN Lab Basic Information List
    Table 102. JOINN Lab Description and Business Overview
    Table 103. JOINN Lab Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business of JOINN Lab (2019-2024)
    Table 105. JOINN Lab Recent Developments
    Table 106. ChemPartner Basic Information List
    Table 107. ChemPartner Description and Business Overview
    Table 108. ChemPartner Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business of ChemPartner (2019-2024)
    Table 110. ChemPartner Recent Developments
    Table 111. Medicilon Basic Information List
    Table 112. Medicilon Description and Business Overview
    Table 113. Medicilon Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business of Medicilon (2019-2024)
    Table 115. Medicilon Recent Developments
    Table 116. EVOTEC Basic Information List
    Table 117. EVOTEC Description and Business Overview
    Table 118. EVOTEC Contract Research Organization (CRO) and CDMO for Pharmaceutical Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business of EVOTEC (2019-2024)
    Table 120. EVOTEC Recent Developments
    Table 121. Key Raw Materials Lists
    Table 122. Raw Materials Key Suppliers Lists
    Table 123. Contract Research Organization (CRO) and CDMO for Pharmaceutical Downstream Customers
    Table 124. Contract Research Organization (CRO) and CDMO for Pharmaceutical Distributors List
    Table 125. Research Programs/Design for This Report
    Table 126. Key Data Information from Secondary Sources
    Table 127. Key Data Information from Primary Sources
    Table 128. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Contract Research Organization (CRO) and CDMO for Pharmaceutical Product Picture
    Figure 2. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value (2019-2030) & (US$ Million)
    Figure 4. Contract Research Organization (CRO) and CDMO for Pharmaceutical Report Years Considered
    Figure 5. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue in 2023
    Figure 7. Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Preclinical CROs Picture
    Figure 9. Clinical CROs Picture
    Figure 10. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Pharmaceutical & Biotechnological Companies
    Figure 13. Product Picture of Medical Device Companies
    Figure 14. Product Picture of Academic & Research Institutes
    Figure 15. Product Picture of Others
    Figure 16. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value (%), (2019-2030)
    Figure 29. United States Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Value by Application (%), 2023 VS 2030
    Figure 50. Contract Research Organization (CRO) and CDMO for Pharmaceutical Industrial Chain
    Figure 51. Contract Research Organization (CRO) and CDMO for Pharmaceutical Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation

Description

The global market for Contract Research Organization (CRO) and CDMO for Pharmaceutical was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Contract Research Organization (CRO) and CDMO for Pharmaceutical, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Contract Research Organization (CRO) and CDMO for Pharmaceutical by region & country, by Type, and by Application.

The Contract Research Organization (CRO) and CDMO for Pharmaceutical market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contract Research Organization (CRO) and CDMO for Pharmaceutical.

Market Segmentation